Covid-19 Variants Could Make Antibody Drugs Less Effective

One company is trying to get ahead of the mutating virus

Photo: Christoph Burgstedt/Science Photo Library/Getty

“It’s an insurance policy in the event of a future outbreak.”

In February, the company launched an early-stage clinical trial to test its antibody drug in healthy participants. Once it’s shown to be safe, the company plans to take the drug into larger trials for the treatment and prevention of Covid-19, including in countries with high rates of resistant variants.

Former staff writer at Medium, where I covered biotech, genetics, and Covid-19 for OneZero, Future Human, Elemental, and the Coronavirus Blog.